UnitedHealth Group Incorporated (NYSE:UNH) Stake Lessened by Park National Corp OH

Park National Corp OH cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,737 shares of the healthcare conglomerate’s stock after selling 251 shares during the period. Park National Corp OH’s holdings in UnitedHealth Group were worth $910,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares during the last quarter. Centre Asset Management LLC acquired a new stake in UnitedHealth Group during the first quarter valued at approximately $3,838,000. Cullen Investment Group LTD. lifted its stake in UnitedHealth Group by 79.0% during the first quarter. Cullen Investment Group LTD. now owns 10,569 shares of the healthcare conglomerate’s stock valued at $5,535,000 after purchasing an additional 4,663 shares during the last quarter. Trust Co of the South lifted its stake in UnitedHealth Group by 1.3% during the first quarter. Trust Co of the South now owns 2,413 shares of the healthcare conglomerate’s stock valued at $1,264,000 after purchasing an additional 31 shares during the last quarter. Finally, Modus Advisors LLC lifted its stake in UnitedHealth Group by 35.1% during the first quarter. Modus Advisors LLC now owns 2,689 shares of the healthcare conglomerate’s stock valued at $1,408,000 after purchasing an additional 699 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $298.11 on Friday. The company’s fifty day moving average is $435.12 and its 200-day moving average is $496.39. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market cap of $270.42 billion, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on UNH. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. HSBC restated a “reduce” rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Finally, Truist Financial reiterated a “buy” rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $441.87.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO John F. Rex purchased 17,175 shares of the firm’s stock in a transaction on Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.